This is a preview of subscription content, log in via an institution to check access.
REFERENCE
McCrone P, Knapp M, Kennedy T, Seed P, Jones R, Darnley S, Chalder T.Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome. European Journal of Gastroenterology and Hepatology 20: 255-263, No. 4, Apr 2008
Rights and permissions
About this article
Cite this article
CBT + mebeverine of value for IBS in short-term. Pharmacoecon. Outcomes News 551, 5 (2008). https://doi.org/10.2165/00151234-200805510-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805510-00014